Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
2025-02-11
Beats Powerbeats Pro 2 review: Apple's first earbuds with heart-rate tracking
The Powerbeats Pro 2 ($250) was hardly a secret. Although Beats officially announced the new fitness-focused earbuds today, it has been teasing them since last September. And over the last few weeks, [...]
2025-03-14
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup
An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. sen [...]
2025-03-27
Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s
Just about a year after launching a direct-to-consumer online platform to sell treatments for diabetes and obesity, Eli Lilly (LLY) is now expanding the program to offer resources for Alzheimer’s d [...]
2025-02-13
Samsung Galaxy Watch 7 review: Incrementally better than its predecessor...again
We called 2023’s Galaxy Watch 6 a “modest upgrade” from the Galaxy Watch 5, which itself also got described as “very similar” to its predecessor, the Watch 4. So it’s perhaps not surprisin [...]
2025-03-24
Novo Nordisk's weight loss drug Wegovy is now cheaper for even more patients
Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half for even more patients that pay without insurance.Read more... [...]
2025-03-28
Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approval
The European Union’s health regulator on Friday rejected Eli Lilly’s (LLY) Alzheimer’s drug, Kisunla, citing risks of brain swelling and bleeding. It’s a major setback for the company as it co [...]